SCHEMBL22674604

SCHEMBL22674604

CCC(=O)N1CCN(Cc2sc3c(N4CCOCC4)nc(-c4cnc(N)nc4)nc3c2C)CC1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 20/20 0.88
MTOR P42345 13/20 0.88
PIK3CB P42338 11/20 0.88
PIK3CD O00329 10/20 0.88
PIK3CG P48736 10/20 0.88
PIK3C2A O00443 1/20 0.80
PIK3C2B O00750 1/20 0.80
STK10 O94804 1/20 0.80
PAK4 O96013 1/20 0.80
ABL1 P00519 1/20 0.80
EGFR P00533 1/20 0.80
FGR P09769 1/20 0.80
FER P16591 1/20 0.80
PRKCA P17252 1/20 0.80
JAK1 P23458 1/20 0.80
TEC P42680 1/20 0.80
SYK P43405 1/20 0.80
PRKDC P78527 1/20 0.80
MAP3K9 P80192 1/20 0.80
BTK Q06187 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1180687 0.93 PIK3CA (1.00) PIK3CAMTORPIK3CBPIK3CDPIK3CG
SCHEMBL1182230 0.93 PIK3CA (1.00) PIK3CAMTORPIK3CBPIK3CDPIK3CG
SCHEMBL1180533 0.91 PIK3CA (0.84) PIK3CAMTORPIK3CBPIK3CDPIK3CG
SCHEMBL1181030 0.91 PIK3CA (0.84) PIK3CAMTORPIK3CBPIK3CDPIK3CG
SCHEMBL1181593 0.90 PIK3CA (0.82) PIK3CAMTORPIK3CBPIK3CDPIK3CG
SCHEMBL1182064 0.89 PIK3CA (1.00) PIK3CAMTORPIK3CBPIK3CDPIK3CG
SCHEMBL20383005 0.89 PIK3CA (0.80) PIK3CAMTORPIK3CBPIK3CDPIK3CG
SCHEMBL19705763 0.89 PIK3CA (0.80) PIK3CAMTORPIK3CBPIK3CDPIK3CG
Apitolisib SCHEMBL466297 0.89 PIK3CA (1.00) PIK3CAMTORPIK3CBPIK3CDPIK3CG
SCHEMBL1181040 0.89 PIK3CA (1.00) PIK3CAMTORPIK3CBPIK3CDPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200360386-A1 Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways for Selective Removal of Senescent Cells in the Treatment of Age Related Conditions UNITY BIOTECHNOLOGY, INC. 2020-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200360386-A1 Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways for Selective Removal of Senescent Cells in the Treatment of Age Related Conditions HSP90AB1, HSP90AB2P, HSP90AA1 PIK3CA 156/4885MTOR 16/4885PIK3CB 302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.